Heart Metabolics bargain with the FDA for a single Phase III

Alizé Pharma Acquires Exclusive Worldwide Rights on a New Peptide to Tackle Bone Diseases

ADVERTISEMENT

2024 biotech deals tracker: the latest partnerships and M&A